Feline Hypertensions - from Epidemiology to Pathophysiology
(Con impuestos)
This webinar will focus on risk factors for hypertension based on large epidemiological studies which inform which patients should be screened for high blood pressure. We will also discuss optimal management of hypertension based on the evidence from clinical trials and longitudinal studies.
This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.
Recording from 14 May 2023
Jonathan Elliott is currently Professor in Veterinary Clinical Pharmacology at the Royal Veterinary College. A Cambridge Veterinary Graduate, his PhD was in vascular biology at the Department of Pharmacology in Cambridge and post-graduate clinical training was undertaken at the University of Pennsylvania. He joined the RVC in 1990 as a lecturer in Veterinary Pharmacology and developed research interests in feline kidney disease and hypertension and equine laminitis. His research has resulted in a number of awards recognising the impact of his work on clinical practice, including the Pfizer Academic Award (1998), BSAVA Amoroso Award (2001), Petplan Charitable Trust Award (2005), ESVNU Scientific Award (2007) and BSAVA Woodrow Award (2019). His is a board member of the International Renal Interest Society and was president of the European College of Veterinary Pharmacology and Toxicology (2018-2021). He has published more than 235 international peer reviewed original papers and reviews and supervised 37 PhD students to completion. He is editor of a number of text books, most recently (2020) Hypertension in the dog and cat published by Springer Nature Switzerland AG (ISBN 978-3-030-33019-4). From 2004-2021 he served as Vice Principal for Research and Innovation at the RVC leading the research strategy for the College and taking responsibility for the submission of last three research excellence framework (REF) exercises.